Vathany Chea, NP
Nurse Practitioner · Fresno, CANPI 1770168544
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (52.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Arthrex accounts for 64.2% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $4,139 and has fallen 94.9% since, to $213 in 2025. Among nurse practitioner clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 73 payments — averaging $62.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Cornerstone Medical Associates, Inc.$1K
- Boston Scientific$441
- Amgen$125
- Bioventus LLC$31
- Endo Pharmaceuticals Inc.$14
What the payments were for
- Travel & lodging$1,24527%
- Food & beverage$89220%
- Education$2,40053%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 16 | $2,914 |
| Cornerstone Medical Associates, Inc. | 3 | $1,011 |
| Boston Scientific | 51 | $441 |
| Amgen | 1 | $125 |
| Bioventus LLC | 1 | $31 |
| Endo Pharmaceuticals Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVENITY$125
How this compares
$4,537 in reported general payments places this provider in the 90th percentile of 6,779 nurse practitioner providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 21 | $630 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 27 | $264 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $212 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Fresno
- Erica BedstedFresno$194K
- Sonja GrowcottFresno$31K
- Rhonda HewittStanford$917K
- Linda TrinhIrvine$884K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.